Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-01-09

Clinical Trial Update: Comparison of Keverprazan Hydrochloride-Amoxicillin Dual Therapy and Susceptibility-Guided Quadruple Therapy for Helicobacter Pylori Rescue Treatment [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Keverprazan hydrochloride-amoxicillin dual therapy versus susceptibility-guided quadruple therapy for Helicobacter pylori rescue treatme…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AMOXICILLIN (AMOXICILLIN)
  • Keverprazan

Snippet

Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University | Conditions: Helicobacter Pylori Infection Helicobacter Pylori Eradication Patient Education | Phase 3 | Status: NOT_YET_RECRUITING